Department of Surgery, Division of Orthopaedic and Trauma Surgery, Oulu University Hospital, Kajaanintie 50, PO Box 21, FI 90029 OYS, Oulu, Finland
Medical Research Centre (MRC) Oulu, Oulu, Finland.
BMJ. 2019 Jan 23;364:k5432. doi: 10.1136/bmj.k5432.
To determine whether treatment of isolated stable Weber B type ankle fractures with a cast or a simple orthotic device for three weeks produces non-inferior outcomes compared with conventional immobilisation in a cast for six weeks.
Randomised, pragmatic, non-inferiority, clinical trial with blinded outcome assessment.
Two major trauma centres in Finland, 22 December 2012 to 6 June 2016.
247 skeletally mature patients aged 16 years or older with an isolated Weber B type fibula fracture and congruent ankle mortise in static ankle radiographs.
Participants were randomly allocated to conventional six week cast immobilisation (n=84) or three week treatment either in a cast (n=83) or in a simple orthosis (n=80).
The primary, non-inferiority, intention-to-treat outcome was the Olerud-Molander Ankle Score at 12 months (OMAS; range 0-100; higher scores indicate better outcomes and fewer symptoms). The predefined non-inferiority margin for the primary outcome was -8.8 points. Secondary outcomes were ankle function, pain, quality of life, ankle motion, and radiographic outcome. Follow-up assessments were performed at 6, 12, and 52 weeks.
212 of 247 randomised participants (86%) completed the study. At 52 weeks, the mean OMAS was 87.6 (SD 18.3) in the six week cast group, 91.7 (SD 12.9) in the three week cast group, and 89.8 (SD 18.4) in the three week orthosis group. The between group difference at 52 weeks for the three week cast versus six week cast was 3.6 points (95% confidence interval -1.9 to 9.1, P=0.20), and for the three week orthosis versus six week cast was 1.7 points (-4.0 to 7.3, P=0.56). In both comparisons, the confidence intervals did not include the predefined inferiority margin of -8.8 points. The only statistically significant between group differences observed in the secondary outcomes and harms in the two primary comparisons were slight improvement in ankle plantar flexion and incidence of deep vein thrombosis, both in the three week orthosis group versus six week cast group.
Immobilisation for three weeks with a cast or orthosis was non-inferior to conventional cast immobilisation for six weeks in the treatment of an isolated stable Weber B type fracture.
ClinicalTrials.gov NCT01758835.
比较用石膏或简单矫形器治疗 3 周与传统石膏固定 6 周治疗孤立稳定型 Weber B 型踝关节骨折的效果,评估 3 周治疗是否不劣于 6 周传统石膏固定。
随机、实用、非劣效性、临床试验,结局评估采用盲法。
芬兰两家大型创伤中心,2012 年 12 月 22 日至 2016 年 6 月 6 日。
247 例骨骼成熟患者,年龄 16 岁及以上,均为静态踝关节 X 线片显示单纯 Weber B 型腓骨骨折且踝穴对位良好。
参与者被随机分配到传统的 6 周石膏固定组(84 例)或 3 周治疗组,分别接受石膏固定(83 例)或简单矫形器固定(80 例)。
主要的非劣效性、意向治疗结局是 12 个月时的 Olerud-Molander 踝关节评分(OMAS;范围 0-100;分数越高表明结局越好,症状越少)。主要结局的非劣效性边界设定为 -8.8 分。次要结局指标包括踝关节功能、疼痛、生活质量、踝关节活动度和影像学结局。随访评估在 6、12 和 52 周进行。
247 例随机参与者中有 212 例(86%)完成了研究。52 周时,6 周石膏固定组的 OMAS 平均为 87.6(SD 18.3)分,3 周石膏固定组为 91.7(SD 12.9)分,3 周矫形器固定组为 89.8(SD 18.4)分。3 周石膏固定组与 6 周石膏固定组的组间差异为 3.6 分(95%置信区间 -1.9 至 9.1,P=0.20),3 周矫形器固定组与 6 周石膏固定组的组间差异为 1.7 分(-4.0 至 7.3,P=0.56)。这两次比较的置信区间均未包含 -8.8 分的劣效性边界。在这两个主要比较中,仅观察到次要结局和不良反应方面有统计学意义的组间差异,即 3 周矫形器组的踝关节跖屈角度略有改善,以及深静脉血栓形成的发生率略高于 6 周石膏固定组。
用石膏或矫形器固定 3 周与传统石膏固定 6 周治疗孤立稳定型 Weber B 型骨折的效果相似。
ClinicalTrials.gov NCT01758835。